Contents of the Financial Statements

for the Period Ended 9 March 2020

Directors' report period ended 9 March 2020

The directors present their report with the financial statements of the company for the period ended 9 March 2020

Directors

The director shown below has held office during the period of
30 September 2019 to 9 March 2020

The directors shown below have held office during the period of
30 August 2019 to 9 March 2020

The director shown below has held office during the period of
13 March 2019 to 30 August 2019

The director shown below has held office during the period of
10 September 2018 to 13 March 2019

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
10 September 2020

And signed on behalf of the board by:
Name: Axel Backheuer
Status: Director

Profit And Loss Account

for the Period Ended 9 March 2020

Balance sheet

As at 9 March 2020

The notes form part of these financial statements

Balance sheet statements

For the year ending 9 March 2020 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The notes form part of these financial statements

Notes to the Financial Statements

for the Period Ended 9 March 2020

• 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Intangible fixed assets amortisation policy

  Intangible fixed assets are shown at cost; net of amortisation and any provision for impairment.Amortisation is provided at rates calculated to write off the cost, less estimated residual value, of intangible fixed assets on a straight-line basis over their estimated useful lives as follows:Developed technology between 15 and 22 yearsTrademarks 15 yearsCustomer relationships 10 yearsThe carrying values of intangible assets are reviewed for impairment when events or changes in circumstances indicate the carrying value may not be recoverable.

  Other accounting policies

  Basis of preparationThe financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 (‘the financial reporting standard applicable in the UK and Republic of Ireland’ FRS 102) issued by the Financial Reporting Council and in accordance with applicable United Kingdom accounting standards and the Companies Act 2006.The functional currency of QIAGEN Healthcare Biotechnologies Systems Ltd is considered to be pounds sterling because that is the currency of the primary economic environment in which the Qiagen Limited operates. The Company’s presentational currency is pounds sterling.The Company meets the definition of a qualifying entity under FRS102 and has therefore taken advantage of certain disclosure exemptions available to it. Exemptions have been taken in relation to:the requirements to disclose a statement of cashflows and the related notes; andthe requirements to disclose intra-group transactions.The group financial statements of QIAGEN N.V., within which this company is included, can be obtained from the company’s registered address, Hulsterweg 82, 5912 PL Venlo, The Netherlands.The directors are continuing to adopt the going concern basis of accounting in preparing the annual financial statements. A forecast for the next 12 months prepared by management has indicated that the entity will have sufficient cash assets to be able to meet its debts as and when they are due. No adjustments have been made relating to recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the entity not continue as a going concern.The financial statements are prepared under the historical cost convention and in accordance with applicable accounting standards. The accounting policies are set out below.Significant judgements and estimatesPreparation of the financial statements requires management to make significant judgements and estimates. The items in the financial statements where these significant judgements and estimates have been made include:Useful economic life and carrying value of intangible fixed assets. The useful lives and residual values are determined by management at the time the asset is acquired and reviewed annually for appropriateness. The lives are based on historical experience with similar assets as well as anticipation of future events which may impact their life such as changes in technology.Actual results could differ from those estimates.Current and deferred taxationThe charge for taxation is based on the profit for the year and takes into account taxation deferred because of timing differences between the treatment of certain items for taxation and accounting purposes.Deferred taxation is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, where transactions or events have occurred at that date, that will result in an obligation to pay more, or right to pay less or to receive more, tax, with the following exception:Deferred tax assets are recognised only to the extent that the directors consider that it is more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.Deferred tax is measured on an undiscounted basis at the tax rates that are expected to apply in the periods in which timing differences reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.Foreign currenciesTransactions denominated in foreign currencies are recorded in sterling at actual exchange rates as of the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are reported at the rates of exchange prevailing at the year end. Any gain or loss arising from a change in exchange rates subsequent to the date of the transaction is included as an exchange gain or loss in the profit and loss account.DebtorsShort term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.CreditorsShort term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.Cash and cash equivalentsCash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Notes to the Financial Statements

for the Period Ended 9 March 2020

• 2. Employees

  	18 months to 9 March 2020
  Average number of employees during the period	0